Biosurgery Sales Specialist - Hospitals & NHS Growth

Johnson & Johnson MedTech; Coventry; On-site; GBP 60,000 - 90,000; Full time

Benefits offered by this job

Digital GP

Private healthcare

Retail vouchers

Discounted gym memberships

Job summary

Johnson & Johnson MedTech in the UK seeks a Biosurgery Sales Specialist to drive growth in NHS and private sector surgical environments across the West Midlands. You will lead key account plans, develop high‑value opportunities, and work with the Biosurgery team to deliver innovative surgical solutions to surgeons and healthcare professionals worldwide.

You will collaborate across the MedTech family, manage diverse stakeholders, and implement strategies that expand biosurgery adoption while

Qualifications

• Proven sales success in Biosurgery or wider surgical environments.
• Extensive knowledge of NHS and Private sector markets across multi‑discipline surgical areas.
• Ability to work with various stakeholders to drive plans and strategies forward.
• Excellent communication, presenting aims clearly and concisely.
• ABPI preferred.

Responsibilities

• Drive sales growth in key centres within the West Midlands territory.
• Develop comprehensive business plans; focus on highest value opportunities.
• Build and develop accounts; align resources to maximise growth.
• Collaborate across the Johnson & Johnson MedTech family to maximise opportunities.
• Manage stakeholder relationships to execute biosurgery strategies effectively.

Skills

Biosurgery sales

NHS market knowledge

Stakeholder management

Multi-disciplinary collaboration

Job description

Johnson & Johnson MedTech in the UK seeks a Biosurgery Sales Specialist to drive growth in NHS and private sector surgical environments across the West Midlands. You will lead key account plans, develop high‑value opportunities, and work with the Biosurgery team to deliver innovative surgical solutions to surgeons and healthcare professionals worldwide.

You will collaborate across the MedTech family, manage diverse stakeholders, and implement strategies that expand biosurgery adoption while